Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003041387 | SCV003443779 | likely benign | not provided | 2024-10-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004070160 | SCV003568814 | uncertain significance | not specified | 2021-07-13 | criteria provided, single submitter | clinical testing | The c.2660C>A (p.S887Y) alteration is located in exon 22 (coding exon 21) of the ITSN2 gene. This alteration results from a C to A substitution at nucleotide position 2660, causing the serine (S) at amino acid position 887 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003926656 | SCV004745506 | likely benign | ITSN2-related disorder | 2020-06-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |